The investment ministry and Malta-based Melabis agreed to grow low-THC cannabis on 3,000 hectares in Sirdaryo, starting with 500 hectares and a $33 million processing plant. The product was to contain 0.1–0.2% THC and be mostly exported for medical use. No domestic cannabis medicine or patient programme followed in the sources read.[1][2]
Listed for context. No score change is recorded for Uzbekistan here.
References
- RFE/RL — Uzbekistan Signs Deal With Maltese Firm To Grow Medical Cannabis (26 November 2020)3,000 hectares in Sardoba, Sirdaryo; first 500 hectares; 0.1–0.2% THC; $33 million; mostly export.
- Azattyq — Узбекистан заключил первое соглашение о выращивании в стране марихуаны для медицинских целей (28 November 2020)Melabis memorandum; 3,000 hectares; 0.1–0.2% THC; export-oriented.archived
Checked. The date and the event were compared with a source that was read.